Birdwatch Note
2024-11-18 05:06:34 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
一般に有意差がないという事は差がないというのと異なるのですが、 https://www.itmedia.co.jp/news/articles/1903/26/news112.html 一般健康診断に関わるランダム化比較試験RCTのメタアナリシスはかなりサンプルサイズが増えた後も、全死亡の短縮効果は検出できていませんが、死亡を増やすという結果も出ていません。以下がコクランのメタ解析です。 https://www.cochrane.org/ja/CD009009/EPOC_bing-qi-tosi-wang-wodi-xia-saserutamenozong-he-jian-zhen https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009009.pub3/full/ja なお、様々な形の、健康指標の限定的な改善につながるというエビデンスは存在します(一例として以下を参照)。 https://www.jstage.jst.go.jp/article/shinzo/53/5/53_417/_pdf/-char/en マンモグラフィーのRCTのメタ解析は乳がんの死亡減少効果を認めています。 https://ganjoho.jp/med_pro/cancer_control/screening/screening_breast.html#:~:text=%EF%BC%91%EF%BC%89%E3%83%9E%E3%83%B3%E3%83%A2%E3%82%B0%E3%83%A9%E3%83%95%E3%82%A3%E5%8D%98%E7%8B%AC%E6%B3%95%EF%BC%8840,%E3%81%A8%E5%88%A4%E6%96%AD%E3%81%95%E3%82%8C%E3%81%BE%E3%81%97%E3%81%9F%E3%80%82 肺がんの検診に関しては低線量CT検査がメタ解析で肺がん死亡を減らすと報告しています。 https://link.springer.com/article/10.1186/s12890-019-0883-x
Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1858326621549449518
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1858376228996321506
- noteId - 1858376228996321506
- participantId -
- noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
- createdAtMillis - 1731906394610
- tweetId - 1858326621549449518
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 一般に有意差がないという事は差がないというのと異なるのですが、 https://www.itmedia.co.jp/news/articles/1903/26/news112.html 一般健康診断に関わるランダム化比較試験RCTのメタアナリシスはかなりサンプルサイズが増えた後も、全死亡の短縮効果は検出できていませんが、死亡を増やすという結果も出ていません。以下がコクランのメタ解析です。 https://www.cochrane.org/ja/CD009009/EPOC_bing-qi-tosi-wang-wodi-xia-saserutamenozong-he-jian-zhen https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009009.pub3/full/ja なお、様々な形の、健康指標の限定的な改善につながるというエビデンスは存在します(一例として以下を参照)。 https://www.jstage.jst.go.jp/article/shinzo/53/5/53_417/_pdf/-char/en マンモグラフィーのRCTのメタ解析は乳がんの死亡減少効果を認めています。 https://ganjoho.jp/med_pro/cancer_control/screening/screening_breast.html#:~:text=%EF%BC%91%EF%BC%89%E3%83%9E%E3%83%B3%E3%83%A2%E3%82%B0%E3%83%A9%E3%83%95%E3%82%A3%E5%8D%98%E7%8B%AC%E6%B3%95%EF%BC%8840,%E3%81%A8%E5%88%A4%E6%96%AD%E3%81%95%E3%82%8C%E3%81%BE%E3%81%97%E3%81%9F%E3%80%82 肺がんの検診に関しては低線量CT検査がメタ解析で肺がん死亡を減らすと報告しています。 https://link.springer.com/article/10.1186/s12890-019-0883-x
Note Ratings
rated at | rated by | |
2024-11-18 17:54:31 -0600 | Rating Details | |
2024-11-18 17:15:04 -0600 | Rating Details | |
2024-11-18 11:08:35 -0600 | Rating Details | |
2024-11-18 08:39:10 -0600 | Rating Details | |
2024-11-18 05:43:58 -0600 | Rating Details | |
2024-11-18 04:47:38 -0600 | Rating Details | |
2024-11-18 04:31:29 -0600 | Rating Details | |
2024-11-18 04:19:42 -0600 | Rating Details | |
2024-11-18 04:16:09 -0600 | Rating Details | |
2024-11-18 04:14:33 -0600 | Rating Details | |
2024-11-18 04:06:34 -0600 | Rating Details | |
2024-11-18 03:53:41 -0600 | Rating Details | |
2024-11-18 03:29:39 -0600 | Rating Details | |
2024-11-18 03:19:27 -0600 | Rating Details | |
2024-11-18 02:14:57 -0600 | Rating Details | |
2024-11-18 02:11:31 -0600 | Rating Details | |
2024-11-18 02:08:36 -0600 | Rating Details | |
2024-11-18 01:54:58 -0600 | Rating Details | |
2024-11-18 01:17:40 -0600 | Rating Details | |
2024-11-18 01:16:39 -0600 | Rating Details | |
2024-11-18 01:10:16 -0600 | Rating Details | |
2024-11-18 01:09:51 -0600 | Rating Details | |
2024-11-18 00:44:11 -0600 | Rating Details | |
2024-11-18 00:42:24 -0600 | Rating Details | |
2024-11-18 00:35:55 -0600 | Rating Details | |
2024-11-18 00:33:47 -0600 | Rating Details | |
2024-11-18 00:18:04 -0600 | Rating Details | |
2024-11-18 00:17:22 -0600 | Rating Details | |
2024-11-18 00:14:17 -0600 | Rating Details | |
2024-11-18 00:10:38 -0600 | Rating Details | |
2024-11-17 23:59:53 -0600 | Rating Details | |
2024-11-17 23:52:39 -0600 | Rating Details | |
2024-11-17 23:52:05 -0600 | Rating Details | |
2024-11-17 23:39:25 -0600 | Rating Details | |
2024-11-17 23:38:14 -0600 | Rating Details | |
2024-11-17 23:38:02 -0600 | Rating Details | |
2024-11-17 23:37:04 -0600 | Rating Details | |
2024-11-19 22:57:54 -0600 | Rating Details | |
2024-11-19 19:20:07 -0600 | Rating Details | |
2024-11-18 19:38:31 -0600 | Rating Details | |
2024-11-18 05:20:28 -0600 | Rating Details | |
2024-11-18 04:09:40 -0600 | Rating Details | |
2024-11-18 03:57:33 -0600 | Rating Details | |
2024-11-18 03:11:37 -0600 | Rating Details | |
2024-11-18 02:44:49 -0600 | Rating Details | |
2024-11-18 02:28:15 -0600 | Rating Details | |
2024-11-18 02:05:53 -0600 | Rating Details | |
2024-11-18 01:51:17 -0600 | Rating Details | |
2024-11-18 00:42:09 -0600 | Rating Details | |
2024-11-18 00:36:49 -0600 | Rating Details | |
2024-11-18 00:15:00 -0600 | Rating Details | |
2024-11-18 00:08:05 -0600 | Rating Details | |
2024-11-18 00:05:34 -0600 | Rating Details | |
2024-11-18 00:03:18 -0600 | Rating Details | |
2024-11-18 00:02:16 -0600 | Rating Details | |
2024-11-17 23:57:57 -0600 | Rating Details | |
2024-11-17 23:55:51 -0600 | Rating Details | |
2024-11-17 23:48:11 -0600 | Rating Details | |
2024-11-17 23:46:34 -0600 | Rating Details | |
2024-11-17 23:38:16 -0600 | Rating Details | |
2024-11-17 23:38:14 -0600 | Rating Details | |
2024-11-17 23:35:33 -0600 | Rating Details | |
2024-11-22 02:20:45 -0600 | Rating Details | |
2024-11-20 06:58:28 -0600 | Rating Details |